Cellectra
-
Plymouth Meeting-based Inovio Delays FDA Approval Plans for Experimental DNA Drug
Plymouth Meeting-based Inovio is delaying plans to seek Food and Drug Administration approval for its experimental DNA medicine as a…
-
FDA Places Clinical Hold on Plymouth Meeting’s Inovio’s COVID-19 Vaccine
The Food and Drug Administration has placed a clinical hold on Plymouth Meeting-based Inovio Pharmaceuticals’ COVID-19 vaccine, writes Justin Heinze…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
